Silver Price Today (Dec. 21, 2025): XAG/USD Holds Near $67 After Record Highs—Latest News, Forecasts, and Key Levels to Watch

Silver Price Today (Dec. 21, 2025): XAG/USD Holds Near $67 After Record Highs—Latest News, Forecasts, and Key Levels to Watch

Silver is closing out 2025 with the kind of momentum that forces both bulls and bears to pay attention. As of Sunday, December 21, 2025, the silver price (XAG/USD) is hovering around the $67-per-ounce area after a record-setting surge late last week—powered by a mix of investment flows, tight supply conditions, and an industrial demand narrative that keeps getting louder. Reuters+1 But this is also the point in a parabolic move where markets tend to change character: liquidity thins into the holidays, positioning gets crowded, and even small headlines can trigger outsized swings. Several analysts publishing today warn that a
Gold Price Today (Dec. 21, 2025): XAU/USD Near $4,350 as Fed “Pause” Talk Meets $5,000 Forecasts for 2026

Gold Price Today (Dec. 21, 2025): XAU/USD Near $4,350 as Fed “Pause” Talk Meets $5,000 Forecasts for 2026

Gold is ending 2025 where it spent much of the year: near record territory, with investors debating whether the next move is a breakout—or a breath. As of Sunday, December 21, 2025, live spot pricing put gold around $4,352/oz, keeping the metal within striking distance of its 2025 record near $4,381/oz and reinforcing the narrative that bullion has shifted from a “rate-cut trade” into a structural portfolio asset for central banks and investors alike. JM Bullion+2Reuters+2 What makes today’s setup especially interesting is the collision of three powerful themes: fresh signals that the Federal Reserve could keep rates steady for
US Stock Market Outlook (Dec. 21, 2025): S&P 500 Eyes a Santa Rally as Fed Signals, AI Jitters, and GDP Data Shape Year-End Trading

US Stock Market Outlook (Dec. 21, 2025): S&P 500 Eyes a Santa Rally as Fed Signals, AI Jitters, and GDP Data Shape Year-End Trading

NEW YORK — The U.S. stock market heads into the final holiday-shortened stretch of 2025 with investors balancing two competing realities: a strong year for major indexes, and a choppier, more skeptical tone beneath the surface as Wall Street debates the durability of the AI-led boom and the next leg of Federal Reserve policy. On Friday’s close (the last full session before Sunday’s outlook pieces), the S&P 500 finished at 6,834.50, the Nasdaq Composite at 23,307.62, and the Dow Jones Industrial Average at 48,134.89. Stocks ended the day higher—helped by a rebound in technology—while the week overall was mixed: the
Dow Jones Industrial Average (DJIA) Outlook: Santa Rally Watch, Fed Signals, and Key Levels After 48,134 Close (Dec. 21, 2025)

Dow Jones Industrial Average (DJIA) Outlook: Santa Rally Watch, Fed Signals, and Key Levels After 48,134 Close (Dec. 21, 2025)

The Dow Jones Industrial Average (DJIA) is heading into the Christmas trading week with a familiar end‑of‑year mix: upbeat annual performance, a choppy December tape, and a market narrative that keeps pivoting between “Santa rally” optimism and late‑cycle caution. The Dow last closed at 48,134.89 on Friday, finishing the day higher but ending the week modestly lower as investors weighed fresh inflation data, AI‑linked volatility, and a Federal Reserve outlook that’s becoming more contested inside the central bank itself. Reuters+1 Dow Jones today: strong year, uneven December In 2025, the big picture still looks constructive. The blue‑chip Dow is up
Accenture Earnings Beat as Advanced AI Bookings Hit $2.2 Billion—But 2026 Outlook Keeps Wall Street Cautious

Accenture Earnings Beat as Advanced AI Bookings Hit $2.2 Billion—But 2026 Outlook Keeps Wall Street Cautious

Accenture’s latest earnings update is a snapshot of where enterprise AI is right now: real budgets, real contracts, and increasingly “baked in” to broader transformation work—yet still paired with investor anxiety about what AI could automate and where spending is tightening. As of December 21, 2025, the consulting and IT services giant is coming off a quarter where it beat revenue expectations, posted strong new bookings, and highlighted a surge in advanced AI demand—while also acknowledging uneven public-sector momentum and offering a second-quarter revenue outlook that landed a touch below what analysts were modeling. Reuters+2Accenture Newsroom+2 The headline numbers: revenue,
Johnson & Johnson (JNJ) Stock Week Ahead: Drug-Pricing Politics, Talc Verdicts, and Fresh FDA Wins Set the Tone (Dec 22–26, 2025)

Johnson & Johnson (JNJ) Stock Week Ahead: Drug-Pricing Politics, Talc Verdicts, and Fresh FDA Wins Set the Tone (Dec 22–26, 2025)

As the market heads into a Christmas-shortened trading week, Johnson & Johnson (NYSE: JNJ) is entering the final stretch of 2025 with an unusually headline-heavy mix of catalysts: U.S. drug-pricing negotiations tied to the White House, new talc-related jury verdicts, and a string of FDA and clinical updates that reinforce the company’s longer-term growth narrative. As of the latest close (Friday, December 19, 2025), JNJ ended around $206/share, keeping the stock in a tight, late-year range while investors weigh whether policy risk and litigation uncertainty outweigh the steadier benefits of new product momentum and “defensive” healthcare positioning. MarketBeat Below is
Exxon Mobil Stock (XOM) Week Ahead Outlook: Oil Prices, Analyst Targets, and Key Catalysts for Dec 22–26, 2025

Exxon Mobil Stock (XOM) Week Ahead Outlook: Oil Prices, Analyst Targets, and Key Catalysts for Dec 22–26, 2025

As of Sunday, December 21, 2025, Exxon Mobil Corporation (NYSE: XOM) is heading into a holiday-shortened trading week with two big forces likely to drive near-term price action: oil-market volatility and fresh investor digestion of Exxon’s upgraded 2030 plan. XOM was last quoted around $116.69. This week’s market structure matters: the NYSE will close early at 1:00 p.m. ET on Wednesday, Dec. 24, and the market will be closed on Thursday, Dec. 25 (Christmas Day). New York Stock Exchange+1 And despite a U.S. federal government closure directive for Dec. 24 and Dec. 26, major U.S. exchanges said they will remain
Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce, Inc. (NYSE: CRM) heads into the Christmas holiday week with a busy backdrop for investors: fresh product distribution news for its Agentforce platform, a newly announced acquisition aimed at “agentic” marketing, and a market calendar that’s likely to amplify day-to-day volatility simply because liquidity is thinner than usual. As of Sunday, December 21, 2025, the latest available trade data puts Salesforce stock around $259.91, following Friday’s (Dec. 19) close. StockAnalysis For the coming week, CRM stock is less about an earnings catalyst (Salesforce just reported) and more about how investors handicap AI monetization, M&A integration, and macro-driven risk appetite
AppLovin (APP) Stock Week Ahead: Fresh Analyst Targets, Axon AI Momentum, and Key Risks to Watch (Dec. 22–26, 2025)

AppLovin (APP) Stock Week Ahead: Fresh Analyst Targets, Axon AI Momentum, and Key Risks to Watch (Dec. 22–26, 2025)

Date: December 21, 2025 (Sunday) — outlook for the coming trading week AppLovin Corporation (NASDAQ: APP) heads into the Christmas-shortened week with investor attention still locked on the same powerful mix that defined much of 2025: rapid growth, unusually high profitability, and a bullish Wall Street narrative around its AI-driven ad engine (Axon). But with APP trading near prior highs after a huge run, the week ahead is less about scheduled company events and more about liquidity, macro headlines, analyst note flow, and any surprise developments tied to regulation or litigation. Below is a detailed, publication-ready, week-ahead report based on
Walmart Stock (WMT) Week Ahead: What to Watch After the Nasdaq Switch, CEO Transition, and Holiday-Shortened Trading Week

Walmart Stock (WMT) Week Ahead: What to Watch After the Nasdaq Switch, CEO Transition, and Holiday-Shortened Trading Week

Dec. 21, 2025 — Walmart Inc. (ticker: WMT) heads into the Christmas week trading window with investors balancing upbeat operational momentum against a burst of headline risk from Washington, regulators, and the courts. The stock last traded around $114.36 after Friday’s close, setting the stage for a holiday-shortened week that can amplify moves—up or down—because liquidity and volume are typically thinner. StockAnalysis This week’s backdrop is unusual even by late-December standards: U.S. markets close early on Wednesday (Dec. 24) and are shut on Thursday (Dec. 25), compressing price discovery into fewer hours. Investopedia+2NYSE+2 Meanwhile, Walmart shareholders are digesting a leadership
BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is ending 2025 with a bang. Shares surged on Friday, December 19, closing at $61.15—up 17.71% on the day—after the company announced a $4.8 billion all-cash acquisition of rare-disease peer Amicus Therapeutics. Trading volume spiked to roughly 18.5 million shares, far above BioMarin’s recent daily activity, underscoring how dramatically the market repriced the story in a single session. Investing.com+2Reuters+2 As of Sunday, December 21, 2025, the weekend narrative around BioMarin stock is dominated by that deal—and what it signals: a sharper pivot toward durable rare-disease commercial franchises, an attempt to reduce dependence on BioMarin’s fast-growing
CoreWeave (CRWV) Stock Week Ahead Forecast: DOE Genesis Mission Boost, Citi “Buy/High Risk,” and Holiday-Week Catalysts (Dec. 22–26, 2025)

CoreWeave (CRWV) Stock Week Ahead Forecast: DOE Genesis Mission Boost, Citi “Buy/High Risk,” and Holiday-Week Catalysts (Dec. 22–26, 2025)

Date: Dec. 21, 2025 (Sunday) — U.S. markets reopen Monday after a volatile week for CoreWeave, Inc. (Nasdaq: CRWV). CoreWeave stock is heading into the Christmas-shortened trading week with momentum—and a spotlight that’s only getting brighter. After a sharp selloff that fueled “AI bubble” chatter across Wall Street, CRWV ripped higher on Friday, Dec. 19, closing at $83.00, up $15.32 (+22.64%) in a single session. MarketBeat What triggered the rebound? Two headlines investors are likely to keep trading in the week ahead: Below is a detailed, week-ahead report on the news, forecasts, and key catalysts shaping CoreWeave stock as of

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop